CRK and cancer: Collectively, our findings demonstrate that PEAK1 is a new non-receptor tyrosine kinase that operates within Src-p130Cas-Crk-Paxillin and Ras-Raf-Erk signaling pathways to regulate cell proliferation, migration and cancer progression [24] (Table 1).